相关实验视频

Updated: Mar 15, 2026

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

神经退行症中的α-synuclein:从共享生物学到疾病特定的表型

Feifei Su¹, Woojin S Kim¹, Glenda M Halliday¹

¹Brain and Mind Centre & Faculty of Medicine and Health School of Medical Sciences, The University of Sydney, Camperdown, NSW 2050, Australia.

|March 14, 2026

概括

这是一种α-synuclein (αSyn) 蛋白质.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
病理学病理学病理学

背景情况:

阿尔法-同核素 (αSyn) 在神经系统中丰富,与同核素病变有关.
它的更广泛的生物作用和疾病贡献是复杂的和多方面的.
了解αSyn的多样性功能对于神经退行性疾病研究至关重要.

研究的目的:

审查除了与疾病的关联之外的α-synuclein (αSyn) 的多方面的生物学.
探索细胞类型,环境,修饰和共病理如何塑造αSyn在疾病中的作用.
整合生理作用与病原性转变,以获得多维视角.

主要方法:

文献综述综合了αSyn研究的最新进展.
对αSyn在神经元和神经细胞中的生理作用的分析.
检查分区特异性功能和翻译后修改 (PTM).

主要成果:

αSyn驱动的疾病是由细胞类型,亚细胞环境,PTM和共同病理的联合影响引起的.
这些因素产生了帕金森病 (PD),勒维体痴呆症 (DLB) 和其他疾病所见的病理多样性.
像ps129这样的分子转换将功能性αSyn转化为致病形式.

结论:

对αSyn生物学的一种多维观点解释了疾病的脆弱性,进展和异质性.
这种观点是了解帕金森病和相关痴呆症的关键.
为不同的αSyn相关疾病提供下一代生物标志物和精确疗法.

关键词:

帕金森病是帕金森氏症的一种疾病.帕金森病痴呆症帕金森病痴呆症这是一种α-synuclein.患有利维体痴呆症的痴呆症格利亚 (Glia) 是一个.多个系统缩.神经元神经元的神经元病理学建模的模型.后翻译修改后的修改种子放大试验试验.

更多相关视频

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein

Published on: July 29, 2022

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Amyloid Fibrils

Amyloid Fibrils